Certest Pharma is dedicated to the development of new solutions for nucleic acid therapeutics through innovative delivery solutions. Specializing lipid nanoparticles (LNP) technology, Certest has developed a proprietary library of ionizable lipids, resulting from a thorough screening over 1,000 lipids. Thus, Certest offers tailor-made, high-performance ionizable lipids with exceptional thermostable LNP properties. Additionally, its RNA platform supports the design, synthesis, scale-up, and evaluation of RNA and oligonucleotides, featuring proprietary UTR sequences, codon optimization software, and in-house production of mRNA synthesis enzymes for superior expression.